COMPASS Pathways(CMPS) - 2024 Q1 - Quarterly Results

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights • Cash position of $262.9 million at March 31, 2024 London, UK – May 8, 2024 Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2024 and provided an update on recent business progress. COMP360 psilocybin treatment in treatment-resistant depression (TRD): ...